Examination of somatostatin involvement in the inhibitory action of GIP, GLP‐1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue
- 1 November 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (5), 1081-1087
- https://doi.org/10.1038/sj.bjp.0702160
Abstract
The effect of a new type 2 selective somatostatin (SRIF) receptor antagonist (DC‐41‐33) on somatostatin‐induced inhibition of pentagastrin‐stimulated gastric acid secretion in conscious, chronic gastric fistula equipped rats was studied. Infused intravenously, DC‐41‐33 dose‐dependently inhibits SRIF‐induced inhibition of pentagastrin‐stimulated gastric acid secretion with an IC50 of 31.6±1.2 nmol kg−1 versus 10 nmol kg−1 SRIF and blocks the inhibitory effects of SRIF when simultaneously co‐infused. Its effectiveness provides additional evidence that SRIF‐inhibition of gastric acid release is a SRIF type 2 receptor‐mediated process. DC‐41‐33 is able to completely reverse the inhibitory effect of glucose‐dependent insulinotropic polypeptides, GIP and GIP‐(1–30)NH2, and glucagon‐like polypeptide, GLP‐1(7‐36)NH2, on pentagastrin‐stimulated gastric acid secretion thus confirming that they exert these effects through stimulation of endogenous SRIF release. DC‐41‐33 only partially blocks potent amylin and adrenomedullin‐induced inhibition of gastric acid secretion, therefore suggesting that somatostatin may not function as a primary mediator in the action of these peptides. Our results indicate that DC‐41‐33, is a potent in vivo inhibitor of exogenous and endogenous SRIF in rats. It represents a new class of SRIF analogues which should eventually provide excellent tools for further evaluating the many physiological roles of SRIF and its five receptor subtypes. British Journal of Pharmacology (1998) 125, 1081–1087; doi:10.1038/sj.bjp.0702160Keywords
This publication has 26 references indexed in Scilit:
- High basal gastric acid secretion in somatostatin receptor subtype 2 knockout miceGastroenterology, 1998
- Potent Antagonists of Somatostatin: Synthesis and BiologyJournal of Medicinal Chemistry, 1998
- Glucagon-Like Peptide-1-(7–36) Amide and Peptide YY Mediate Intraduodenal Fat-Induced Inhibition of Acid Secretion in Dogs*Endocrinology, 1998
- Characterization of somatostatin receptor subtypes mediating inhibition of nutrient-stimulated gastric acid and gastrin in dogsRegulatory Peptides, 1997
- Amylin given by central and peripheral routes inhibits acid gastric secretionPeptides, 1994
- Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouseGastroenterology, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Effect of Glucagon-Like Peptide-1 on Gastric Somatostatin and Gastrin Secretion in the RatScandinavian Journal of Gastroenterology, 1990
- Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitusBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987